Introduction
Identification of breast cancer susceptibility alleles
Gene | Monoallelic mutation | Biallelic mutations | Risk for breast cancer | Reference |
---|---|---|---|---|
BRCA1
| Breast and ovarian cancer | Microcephaly and growth disorder | high | |
BRCA2
| Breast and ovarian cancer | Fanconi anemia type D1 | high | |
TP53
| Li Fraumeni Syndrome | - | high | |
PTEN
| PTEN harmatoma tumour syndrome (Cowden Disease) | - | high | |
LKB1
| Peutz-Jeghers Syndrome | - | high | |
MLH1
| Lynch Syndrome | - | probably intermediate (high for endometrial and colon cancer) | [13] |
MSH2
| Lynch Syndrome/Muir-Torre Syndrome | - | probably intermediate (high for endometrial and colon cancer) | [13] |
CDH1
| Lobular breast cancer, diffuse gastric cancer | - | high | |
PALB2
| Breast cancer | Fanconi anemia type N | intermediate to high | |
UIMC1
| Breast cancer1
| - | level not yet known | [27] |
FAM175A
| Breast cancer1
| - | level not yet known | [28] |
RAD51C
| Breast and ovarian cancer2
| Fanconi anemia type O | low to intermediate (high for ovarian cancer) | |
RAD51D
| Breast and ovarian cancer2
| - | low to intermediate (high for ovarian cancer) | |
BRIP1
| Breast and ovarian cancer | Fanconi anemia type J | low to intermediate (high for ovarian cancer) | |
ATM
| Breast cancer, pancreatic cancer | Ataxia telangiectasia | intermediate | |
MRE11A
| Breast cancer1
| Ataxia telangiectasia-like disorder | level not yet known | [40] |
NBN
| Breast cancer, prostate cancer | Nijmegen Breakage syndrome | intermediate | |
RAD50
| Breast cancer | Nijmegen Breakage-like disorder | intermediate | [44] |
BLM
| Breast cancer | Bloom’s Syndrome | intermediate | |
FANCC
| Breast cancer1
| Fanconi anemia type C | intermediate in FA blood relatives | |
FANCM
| Breast cancer1
| Fanconi anemia type M | probably intermediate | [49] |
SLX4
| Breast cancer1
| Fanconi anemia type P | level not yet known | |
XRCC2
| Breast cancer1
| - | level not yet known | |
CHEK2
| Breast cancer, prostate cancer | breast cancer | intermediate | |
PPM1D
| Breast cancer3, ovarian cancer3
| - | possibly intermediate (high for ovarian cancer), non-inherited | [59] |
Locus | SNP | Reported gene | Nearby genes (selected) | Association with ER status | Reference |
---|---|---|---|---|---|
1p11 | rs2580520, rs11249433 |
EMBP1
|
HIST3, HIST2H2BA
| ER + ve ~ ER-ve | |
1p13 | rs11552449 |
DCLRE1B
|
PTPN22, HIPK1, BCL2L15
| ER + ve > ER-ve | [72] |
1p36 | rs616488 |
PEX14
|
KIF1B, UBE4B, RBP7
| ER-ve > ER + ve | [37] |
1q32 | rs4245739 |
MDM4
|
PIK3C2B
| ER-ve | [115] |
1q32 | rs6678914 |
LGR6
|
UBE2T, PTPN7
| ER-ve | [115] |
2p24 | rs12710696 | intergenic |
OSR1
| ER-ve | [115] |
2q14 | rs4849887 | intergenic |
INHBB, RALB, GLI2
| ER + ve ~ ER-ve | [72] |
2q31 | rs2016394 | intergenic |
DLX1, DLX2, ITGA6, PDK1
| ER + ve | [72] |
2q31 | rs1550623 | intergenic |
CDCA7, MLK7-AS1, ZAK
| ER + ve ~ ER-ve | [72] |
2q33 | rs1045485, rs10931936, rs3834129- rs6723097-rs3817578 |
CASP8
|
CASP10, ORC2, CDK15
| ER + ve ~ ER-ve | |
2q34 | rs13393577 |
ERBB4
|
MIR4776
| ER + ve ~ ER-ve | [110] |
2q35 | rs13387042, rs16857609 |
DIRC3
|
PINC, TNS1, IGFBP1, IGFBP5
| ER + ve > ER-ve | |
3p24 | rs4973768 |
SLC4A7
|
NEK10
| ER + ve > ER-ve | |
3p24 | rs12493607 |
TGFBR2
|
GADL1
| ER + ve | [72] |
3p26 | rs10510333 | intergenic |
GRM7
| ER + ve ~ ER-ve | [113] |
3p26 | rs6762644 |
ITPR1
|
SUMF1, BHLHE40
| ER + ve | [72] |
3q25 | rs6788895 |
SIAH2
|
MED12L, SELT, EIF2A
| ER + ve | [112] |
3q26 | rs3806685 | intergenic |
PIK3CA, ZNF639
| ER + ve ~ ER-ve | [110] |
4q24 | rs9790517 |
TET2
|
PPA2
| ER + ve | [72] |
4q34 | rs6828523 |
ADAM29
|
GLRA3
| ER + ve | [72] |
5q11 | rs889312, rs16886165 | intergenic |
MAP3K1, MIER3
| ER + ve > ER-ve | |
5q11 | rs1353747, rs10472076 |
PDE4D
|
RAB3C, PDK2
| ER + ve ~ ER-ve | [72] |
5p12 | rs4415084, rs10941679, rs7716600, rs9790879, rs4866929 | intergenic |
HCN1, MRPS30,FGF10
| ER + ve > ER-ve | |
5p15 | rs1092913 | intergenic |
MARCH6, DAP
| ER + ve > ER-ve | |
5p15 | rs2736108, rs10069690, rs2242652 |
TERT
|
CLPTM1L
| variant specific | |
5q33 | rs1432679 |
EBF1
|
RNF145, UBLCP1
| ER + ve ~ ER-ve | [72] |
6p23 | rs204247 | intergenic |
RANBP9, SIRT5, CCDC90A
| ER + ve | [72] |
6p24 | rs9348512 | intergenic |
GCNT2, PAK1IP1, TFAP2A
|
BRCA2 specific | [118] |
6p25 | rs11242675 | intergenic |
FOXQ1, FOXF2, FOXC1
| ER + ve ~ ER-ve | [72] |
6q14 | rs17529111, rs17530068 | intergenic |
FAM46A, IBTK, SSBP2
| ER + ve ~ ER-ve | |
6q25 | rs9498283 |
TAB2
|
SUMO4, LATS1
| ER + ve ~ ER-ve | [110] |
6q25 | rs3757318, rs12662670, rs6929137, rs3734804, rs3734805, rs2046210 | intergenic |
ESR1
| variant specific | |
7q32 | rs2048672 |
FLJ43663
|
MIR29A, KLF14
| not mentioned | [106] |
7q35 | rs720475 |
ARHGEF5
|
NOBOX
| ER + ve | [72] |
8p12 | rs9693444 | intergenic |
DUSP4, KIF13B
| ER + ve ~ ER-ve | [72] |
8q21 | rs6472903, rs2943559 |
HNF4G
|
CRISPLD1, ZFHX4
| ER + ve > ER-ve | [72] |
8q24 | rs672888, rs1562430, rs13281615, rs11780156 | intergenic |
PVT1, MIR1204-08, MYC
| ER + ve ~ ER-ve | |
9p21 | rs1011970 |
CDKN2B
|
CDKN2A, CDKN2B-AS1
| ER + ve > ER-ve | [101] |
9q31 | rs865686, rs10759243 | intergenic |
RAD23B, KLF4
| ER + ve > ER-ve | |
10p12 | rs7072776, rs11814448 | intergenic |
DNAJC1, MLLT10
| ER + ve ≠ ER-ve | [72] |
10p15 | rs2380205 | intergenic |
ANKRD16, FBXO18, GDI2
| ER + ve ~ ER-ve | [101] |
10q21 | rs10822013, rs10995190 |
ZNF365
|
EGR2, NRBF2
| ER + ve > ER-ve | |
10q22 | rs704010, rs12355688 |
ZMIZ1
|
PPIF, ZCCHC24, EIF5AL1
| ER + ve ~ ER-ve | |
10q25 | rs7904519 |
TCF7L2
|
ZDHHC6, CASP7, DCLRE1A
| ER + ve ~ ER-ve | [72] |
10q26 | rs2981582, rs11199914, rs2981579, rs1219648, rs10510102 |
FGFR2
|
WDR11, TACC2
| ER + ve | |
11p15 | rs3817198, rs909116 |
LSP1-TNNT3
|
CTSD, DUSP8, IGF2
| ER + ve ~ ER-ve | |
11q13 | rs3903072 | intergenic |
RELA, MAP3K11, MUS81
| ER + ve | [72] |
11q13 | rs614367, rs661204, rs78540526, rs554219, rs657686, rs75915166 | intergenic |
CCND1, FGF19, FGF4, FGF3
| ER + ve > ER-ve | |
11q24 | rs11820646 | intergenic |
BARX2, NFRKB, PRDM10
| ER + ve ~ ER-ve | [72] |
12p11 | rs10771399 |
PTHLH
|
CCDC81
| ER + ve ~ ER-ve | [108] |
12p13 | rs12422552 | intergenic |
ATF7IP, GRIN2B, PLBD1
| ER + ve ~ ER-ve | [72] |
12q22 | rs17356907 | intergenic |
NTN4, USP44, METAP2, NR2C1 VEZT, FGD6, CCDC38
| ER + ve ~ ER-ve | [72] |
12q24 | rs1292011 | intergenic |
TBX3
| ER + ve > ER-ve | [108] |
14q13 | rs2236007 |
PAX9
|
NKX2-8
| ER + ve > ER-ve | [72] |
14q24 | rs999737, rs2588809, rs1314913, rs10483813, rs8009944, |
RAD51B
|
ZFP36, ACTN1, DCAF5
| ER + ve | |
14q31 | rs4322600 |
GALC
|
GPR65
| ER + ve ~ ER-ve | [113] |
14q32 | rs941764 |
CCDC88C
|
GPR68, SNORA11B, RPS6KA5, SMEK1, CATSPERB, TC2N
| ER + ve | [72] |
16q12 | rs3803662 | intergenic |
TNRC9/TOX3, MIR548, CHD9
| ER + ve > ER-ve | |
16q12 | rs17817449, rs11075995 |
FTO
|
AKTIP, RBL2, CHD9
| ER + ve ~ ER-ve | |
16q23 | rs13329835 |
CDYL2
|
CENPN, ATMIN, GCSH, PKD1L2
| ER + ve > ER-ve | [72] |
17q22 | rs6504950, rs1156287 |
STXBP4
|
COX11, HLF
| ER + ve > ER-ve | |
17q24 | rs11077488 | intergenic |
KCNJ2, KCNJ16
| Not mentioned | [110] |
18q11 | rs527616, rs1436904 |
CHST9
|
KCTD1, TAF4B
| ER + ve > ER-ve | [72] |
19p13 | rs8170, rs8100241, rs2363956 |
BABAM1
|
ANKLE1
| ER-ve | |
19p13 | rs4808801 |
ELL
|
SSBP4, FKBP8, PDE4C
| ER + ve ~ ER-ve | [72] |
19q13 | rs3760982 | intergenic |
ZNF Cluster, KCNN4, SMG9, XRCC1
| ER + ve ~ ER-ve | [72] |
19q13 | rs10411161, rs3848562 |
ZNF577
|
MIR125A, ZNF Cluster
| Not mentioned | [105] |
20q11 | rs2284378 |
RALY
|
ASIP, EIF2S2, CHMP4B, ZNF341, E2F1
| ER-ve | [109] |
21q21 | rs2823093 | intergenic |
NRIP1
| ER + ve > ER-ve | [108] |
22q12 | rs132390 |
EMID1
|
KREMEN1, CHEK2, EWSR1, NF2
| ER + ve ~ ER-ve | [72] |
22q13 | rs6001930 |
MKL1
|
SGSM3, ADSL, MCHR1, XPNPEP3, DNAJB7, RBX1
| ER + ve ~ ER-ve | [72] |
22q13 | CNV2576, tagged by rs12628403 |
APOBEC3A- APOBEC3B
|
APOBEC3C
| ER + ve ~ ER-ve | [130] |